Clinical Trials Update from NCI, July 2024

https://content.govdelivery.com/accounts/USNIHNCI/bulletins/3abc76e?reqfrom=share Immunotherapy Approach Shows Potential in Some People with Metastatic Solid Tumors Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from NCI genetically modified normal white blood cells, known as lymphocytes, from each patient to produce receptors that recognize and attack their specific cancer cells.